1. Home
  2. CSPI vs RFL Comparison

CSPI vs RFL Comparison

Compare CSPI & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CSP Inc.

CSPI

CSP Inc.

HOLD

Current Price

$8.49

Market Cap

85.6M

Sector

Technology

ML Signal

HOLD

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

HOLD

Current Price

$2.64

Market Cap

92.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSPI
RFL
Founded
1968
2017
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Real Estate
Sector
Technology
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
85.6M
92.6M
IPO Year
1994
2017

Fundamental Metrics

Financial Performance
Metric
CSPI
RFL
Price
$8.49
$2.64
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
27.6K
274.0K
Earning Date
05-08-2026
06-10-2026
Dividend Yield
1.15%
N/A
EPS Growth
75.00
28.28
EPS
0.04
N/A
Revenue
$58,730,000.00
$917,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$219.00
N/A
Revenue Growth
6.36
43.96
52 Week Low
$7.55
$1.12
52 Week High
$15.00
$2.95

Technical Indicators

Market Signals
Indicator
CSPI
RFL
Relative Strength Index (RSI) 40.26 73.51
Support Level $7.98 $1.22
Resistance Level $9.31 N/A
Average True Range (ATR) 0.69 0.32
MACD -0.04 0.06
Stochastic Oscillator 19.14 81.75

Price Performance

Historical Comparison
CSPI
RFL

About CSPI CSP Inc.

CSP Inc develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments, namely Technology Solutions, where the company focuses on value-added reseller integrated solutions, including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company designs, manufactures, and delivers products and services to customers that require specialized cybersecurity services, networking, and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates the majority of its revenue from the Americas.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: